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the isolates studied.
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esβ-Lactams, the antibiotics most frequently used to treat bac-
terial infections diseases [1] are becoming less useful against
enterobacteria. The principal cause of this decrease in efﬁcacy is
the production of extended-spectrum β-lactamases (ESBLs) by
these bacteria [1]. In Senegal, only limited molecular charac-
terization data are available for ESBL genes. The overall aim of
this study was to detect the ESBLs produced by clinical strains
of Escherichia coli isolated at Fann University Hospital in Dakar.
Our speciﬁc objective was to use molecular biology tests to
characterize the genes encoding these enzymes.New Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artiWe studied 32 ESBL-producing isolates of E. coli obtained
from urine, blood, pus and vaginal secretions. After their
isolation and identiﬁcation between 2009 and 2010, these iso-
lates were stored at −80°C until their molecular characteriza-
tion. The API 20E panel (bioMérieux, Marcy l’Etoile, France)
was used for identiﬁcation. Antibiogram analyses were carried
out by the disc diffusion method on Müller-Hinton agar. ESBLs
were detected in tests of synergy between discs carrying third-
generation cephalosporins (ceftriaxone, ceftazidime, cefotax-
ime) and discs carrying amoxicillin–clavulanic acid. The results
were interpreted according to the recommendations of the
Comité de l’Antibiogramme de la Société Française de Micro-
biologie (http://www.sfm-microbiologie.org/).
Molecular biology tests were carried out at the Bacteriology
Laboratory of Pierre et Marie Curie University (Paris VI),
France. Total DNA was extracted from the isolates with Qia-
gen minikits (Qiagen, Germantown, MD, USA). We used for-
ward and reverse primers for the TEM, SHV, CTX-M-9, CTX-M-
15, CTX-M-25 and OXA-1 genes [2,3]. PCR products were
subjected to electrophoresis in a 3% agarose gel at 100 V for 40
minutes and were puriﬁed with the ExoSAP-IT enzyme.
Nucleotide sequences were determined by direct Sanger
sequencing on an Applied Biosystems 3730 XL sequencer, with
the Big Dye Terminator 3.1 cycle sequencing kit (Applied
Biosystems, Foster City, CA, USA).
All 32 E. coli isolates were susceptible to imipenem. PCR
ampliﬁcation identiﬁed the following four genes: TEM, SHV,
OXA-1 and CTX-M-15, with a predominance of the CTX-M-15
gene (90.63%; Fig. 1).
To our knowledge, this is one of the ﬁrst studies to report the
isolation of strains of E. coli producing CTX-M-15-type ESBLs in
Senegal. This type of ESBL was identiﬁed in several previous
Senegalese studies: a study of 11 enterobacterial isolates,
including one E. coli isolate [4], and a study of 112 enterobacterialFIG. 1. Distribution of genes found in Escherichia coli.
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Salmonella enterica strains [6]. Our study of 32 isolates of E. coli,
90.63% of which harboured the CTX-M-15 gene, showed that
isolates of this type are becoming increasingly common in
Senegal, as they are elsewhere in the world [1]. CTX-M-15-type
ESBLs have also been found in E. coli strains in Nigeria [3] and
enterobacterial strains in India [7]. The secretion of this enzyme
by a strain confers high levels of resistance to cefotaxime, cef-
triaxone, ceftazidime and aztreonam [8].
This study shows that E. coli strains producing CTX-M-15
ESBLs are circulating in Senegal. Wider surveys are now
required to determine the extent to which CTX-M-15-pro-
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